SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Loechner David

(Last)

(First)

(Middle)

EMERALD EXPOSITIONS EVENTS, INC.

31910 DEL OBISPO STREET, SUITE 200

(Street)

SAN JUAN CAPISTRANO

92675

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/28/2017

3. Issuer Name and Ticker or Trading Symbol
Emerald Expositions Events, Inc. [ EEX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO & President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	105,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	07/19/2023	Common Stock	957,500	$8	D
Stock Option (Right to Buy)	⁽²⁾	07/19/2023	Common Stock	441,250	$12	D
Stock Option (Right to Buy)	⁽²⁾	07/19/2023	Common Stock	441,250	$16	D
Stock Option (Right to Buy)	⁽³⁾	02/26/2024	Common Stock	30,000	$8	D
Stock Option (Right to Buy)	⁽⁴⁾	04/22/2024	Common Stock	181,250	$8	D
Stock Option (Right to Buy)	⁽⁵⁾	04/22/2024	Common Stock	90,625	$12	D
Stock Option (Right to Buy)	⁽⁵⁾	04/22/2024	Common Stock	90,625	$16	D
Stock Option (Right to Buy)	⁽⁶⁾	12/15/2024	Common Stock	28,500	$10.4	D
Stock Option (Right to Buy)	⁽⁷⁾	12/15/2024	Common Stock	14,250	$12	D
Stock Option (Right to Buy)	⁽⁷⁾	12/15/2024	Common Stock	14,250	$16	D

Explanation of Responses:

1. This option is vested with respect to 574,500 underlying shares and will vest with respect to the remaining 383,000 underlying shares in equal installments on July 19, 2017 and July 19, 2018.

2. This option is vested with respect to 264,750 underlying shares and will vest with respect to the remaining 176,500 underlying shares in equal installments on July 19, 2017 and July 19, 2018.

3. This option is vested with respect to 18,000 underlying shares and will vest with respect to the remaining 12,000 underlying shares in equal installments on February 26, 2018 and February 26, 2019.

4. This option is vested with respect to 108,750 underlying shares and will vest with respect to the remaining 72,500 underlying shares in equal installments on April 22, 2018 and April 22, 2019.

5. This option is vested with respect to 54,375 underlying shares and will vest with respect to the remaining 36,250 underlying shares in equal installments on April 22, 2018 and April 22, 2019

6. This option is vested with respect to 11,400 underlying shares and will vest with respect to the remaining 17,100 underlying shares in equal installments on December 15, 2017, December 15, 2018 and December 15, 2019

7. This option is vested with respect to 5,700 underlying shares and will vest with respect to the remaining 8,550 underlying shares in equal installments on December 15, 2017, December 15, 2018 and December 15, 2019.

	/s/ David Gosling, Attorney-in-Fact for David Loechner	04/28/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.